- KKR’s McVey Says Markets Are Pricing In a Biden Victory
- BlackRock’s Kosterich: Rates Can Tick Higher, But Not Melt Up
Stories You May Also Like:
AbbVie retains Humira market despite copycats (NYSE:ABBV)
vzphotos AbbVie (NYSE:ABBV) has continued to maintain near 100% market share for its blockbuster arthritis therapy Humira (adalimumab) despite the
